Melanoma gave science a window into the role immune evasion plays in the development of malignancy. The entire spectrum of immune focused anti-cancer therapies has been subjected to clinical trials in this disease, with limited success until the immune checkpoint blockade era. That revolution launched first in melanoma, heralded a landscape change throughout cancer that continues to reverberate today.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-3-030-96376-7_2 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!